Theravance Biopharma, Inc. Inventory Write-down
Theravance Biopharma, Inc. (TBPH) reported Inventory Write-down of $740.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-02-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2020-02-27
- Theravance Biopharma, Inc. inventory write-down for the quarter ending 2017-12-31 was $97.00K, a 67.67% decline year-over-year.
- Theravance Biopharma, Inc. inventory write-down for the quarter ending 2017-09-30 was $1.00K.
- Theravance Biopharma, Inc. inventory write-down for the quarter ending 2017-06-30 was $642.00K, a 488.99% increase year-over-year.
- Theravance Biopharma, Inc. inventory write-down for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
- Theravance Biopharma, Inc. inventory write-down for fiscal 2017 was $740.00K, a 144.22% increase from fiscal 2016.
- Theravance Biopharma, Inc. inventory write-down for fiscal 2016 was $303.00K, a 85.54% decline from fiscal 2015.
- Theravance Biopharma, Inc. inventory write-down for fiscal 2015 was $2.10M, a 27.40% decline from fiscal 2014.
- Theravance Biopharma, Inc. inventory write-down for fiscal 2014 was $2.89M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2017-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $98.00K derived: sum of 2 quarters · filed 2020-02-27 | $740.00K derived: sum of 3 quarters · filed 2020-02-27 | $740.00K 10-K · filed 2020-02-27 |
| 2017-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $643.00K derived: sum of 2 quarters · filed 2018-11-08 | $643.00K 10-Q · filed 2018-11-08 | $943.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $642.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $642.00K 10-Q · filed 2018-08-02 | $942.00K derived: sum of 3 quarters · filed 2018-08-02 | $942.00K derived: sum of 4 quarters · filed 2018-08-02 |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-10 | $300.00K derived: sum of 2 quarters · filed 2017-05-10 | $300.00K derived: sum of 3 quarters · filed 2017-11-08 | $409.00K derived: sum of 4 quarters · filed 2017-11-08 |
| 2016-12-31 | $300.00K 10-K · filed 2017-03-01 | $300.00K derived: sum of 2 quarters · filed 2017-11-08 | $409.00K derived: sum of 3 quarters · filed 2017-11-08 | $303.00K 10-K · filed 2019-02-28 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $109.00K derived: sum of 2 quarters · filed 2017-11-08 | $119.00K 10-Q · filed 2017-11-08 | $2.14M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | $109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $119.00K 10-Q · filed 2017-08-09 | $2.14M derived: sum of 3 quarters · filed 2018-02-28 | $2.14M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | $10.00K 10-Q · filed 2017-05-10 | $2.03M derived: sum of 2 quarters · filed 2018-02-28 | $2.03M derived: sum of 3 quarters · filed 2018-02-28 | $2.03M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $2.02M derived: sum of 2 quarters · filed 2018-02-28 | $2.02M derived: sum of 3 quarters · filed 2018-02-28 | $2.10M 10-K · filed 2018-02-28 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $79.00K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $79.00K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $79.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $2.89M 10-K · filed 2017-03-01 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $0.00 10-Q · filed 2015-08-13 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-13 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-11 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |